References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Acetoetal(1989)Verylong-actingnarcoticantagonists.The14β-p-substitutedcinnamoylaminomorphinonesandtheirpartialmuagonistcodeinonerelatives.Arzneimittelforschung39570PMID:2547389
Burkeetal(1994)Irreversibleopioidantagonisteffectsofclocinnamoxonopioidanalgesiaandmureceptorbindinginmice.J.Pharmacol.Exp.Ther.271715PMID:7965787
Zernigetal(1996)Mechanismofclocinnamoxblockadeofopioidreceptors:evidencefrominvitroandexvivobindingandbehaviouralassays.J.Pharmacol.Exp.Ther.27923PMID:8858971
Broadbearetal(2000)Methocinnamoxisapotent,long-lasting,andselectiveantagonistofmorphine-mediatedantinociceptioninthemouse:comparisonwithclocinnamox,β-funaltrexamine,andβ-chlornaltrexamine.J.Pharmacol.Exp.Ther.294933PMID:10945843
Keywords:Clocinnamoxmesylate,supplier,irreversible,mu-opioids,m-opioids,μ-opioids,receptors,antagonists,NIH,10443,C-CAM,Mu,Opioid,Receptors,Mu,Opioid,Receptors,TocrisBioscience